Skip to content

Effectiveness of a Virtual Intervention for Professionals to Improve Their Attitudes Towards Patient Empowerment.

Effectiveness of a Virtual Intervention (CoP) for Professionals to Improve Their Attitude Towards the Empowerment of Patients With Chronic Disease: Cluster Randomised Controlled Trial (eMPODERA Project)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02757781
Acronym
eMPODERA
Enrollment
272
Registered
2016-05-02
Start date
2016-07-31
Completion date
2018-12-31
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease

Keywords

Patient empowerment, Patient involvement, Patient participation, Healthcare professional attitudes, Chronic diseases

Brief summary

The eMPODERA study aims to assess the effectiveness of a Community of Practice (CdP) virtual in improving attitudes of primary care professionals on the empowerment of patients with chronic diseases.

Detailed description

Main Objective: to assess the effectiveness of a Community of Practice (CdP) virtual in improving attitudes of health professionals in primary care on the empowerment of patients with chronic diseases. Methodology: Design: cluster randomised controlled. Scope: primary care centers (PCC) belonging to the Regions of Catalonia, Madrid and Canary Islands. Population: primary care health professionals (family doctors and nurses). Sample size: 270 healthcare professionals and 1382 patients. Randomization: Randomization unit: PCC; unit of analysis: primary care health professionals. 9 pairs of PCC by region will be randomly selected and randomly assigned to the intervention or control group. Randomization will be performed after the selection of professionals and patients. Intervention: the intervention group will be offered participation for 12 months in a virtual CdP based on a web 2.0 platform. The control group will receive usual training. Measurements: the primary outcome will be measured by Patient-Provider Orientation Scale (PPOS) questionnaire at baseline and 12 months. Secondary outcomes: sociodemographic of professionals; sociodemographic and clinical characteristics of patients; Patient Activation Measure (PAM) questionnaire for patient activation; outcomes regarding use of the CdP. Analysis: A linear mixed-effects regression to estimate the effect of participating in the CdP will be estimated. Additionally, an analysis of how the CdP is functioning through techniques of social network analysis and control charts will be performed.

Interventions

BEHAVIORALCommunity of Practice

The intervention group will be offered participation for 12 months in a virtual CdP based on a web 2.0 platform. The control group will receive usual training.

Sponsors

Servicio Canario de Salud
CollaboratorOTHER
Gerencia de Atención Primaria, Madrid
CollaboratorOTHER_GOV
Avedis Donabedian Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Clusters: * Primary Care Centres (PCC) with Electronic Record system with more than 1 year of implementation * PCC belongs to the Automonous Comunities of Canary Island, Catalonia and Madrid Healthcare professionals: * Acceptance to participate * stable contract with the Primary care centre * Physician or Nurses

Exclusion criteria

Clusters: \- Primary Care Centres where its directors do not accept to participate in the trial Healthcare professionals: * Students * Medical and Nursing residents

Design outcomes

Primary

MeasureTime frameDescription
Change from Patient-Provider Orientation Scale (PPOS) at 12 monthsAt baseline and 12 monthsPPOS is a questionnaire administrated to healthcare professionals

Secondary

MeasureTime frameDescription
Change from Patient Activation Measure (PAM) at 12 monthsBaseline and 12 monthsPAM is validated questionnaire to measure patient activation (administrated to patients)

Contacts

Primary ContactCarola Orrego, PhD
corrego@fadq.org34 932076608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026